344 related articles for article (PubMed ID: 28489670)
1. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children.
Rubinstein E; Lee JJ; Fried A; Logvinenko T; Ngo P; McDonald D; Hait EJ
J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):317-20. PubMed ID: 24821535
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
[TBL] [Abstract][Full Text] [Related]
5. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
Dohil R; Newbury R; Fox L; Bastian J; Aceves S
Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
[TBL] [Abstract][Full Text] [Related]
6. Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis.
Rubinstein E; Hait EE; Mitchell PD; Lee JJ
J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):395-397. PubMed ID: 28837508
[TBL] [Abstract][Full Text] [Related]
7. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
[TBL] [Abstract][Full Text] [Related]
8. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I;
Gastroenterology; 2017 Mar; 152(4):776-786.e5. PubMed ID: 27889574
[TBL] [Abstract][Full Text] [Related]
9. Comparison of budesonide vehicles in inducing histologic remission in pediatric eosinophilic esophagitis.
Lendner N; Minich NM; Malay S; Sferra TJ; Young DD
J Pediatr Gastroenterol Nutr; 2024 May; ():. PubMed ID: 38803200
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U
Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589
[TBL] [Abstract][Full Text] [Related]
11. Adrenal Insufficiency after Chronic Swallowed Glucocorticoid Therapy for Eosinophilic Esophagitis.
Golekoh MC; Hornung LN; Mukkada VA; Khoury JC; Putnam PE; Backeljauw PF
J Pediatr; 2016 Mar; 170():240-5. PubMed ID: 26687577
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis.
Eluri S; Selitsky SR; Perjar I; Hollyfield J; Betancourt R; Randall C; Rusin S; Woosley JT; Shaheen NJ; Dellon ES
Clin Gastroenterol Hepatol; 2019 May; 17(6):1081-1088.e2. PubMed ID: 30213583
[TBL] [Abstract][Full Text] [Related]
13. Variability in Swallowed Topical Corticosteroid Practice Patterns for Treatment of Pediatric Eosinophilic Esophagitis.
Syverson EP; Tobin M; Patton T; Franciosi JP; Gupta SK; Venkatesh RD
J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):256-259. PubMed ID: 37204839
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis.
Kia L; Nelson M; Zalewski A; Gregory D; Gonsalves N; Straumann A; Hirano I
Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 30380044
[TBL] [Abstract][Full Text] [Related]
15. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis.
Dellon ES; Sheikh A; Speck O; Woodward K; Whitlow AB; Hores JM; Ivanovic M; Chau A; Woosley JT; Madanick RD; Orlando RC; Shaheen NJ
Gastroenterology; 2012 Aug; 143(2):321-4.e1. PubMed ID: 22561055
[TBL] [Abstract][Full Text] [Related]
16. Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial.
Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Galanko JA; Baron JA; Shaheen NJ
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1483-1492.e2. PubMed ID: 31499249
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis.
Butz BK; Wen T; Gleich GJ; Furuta GT; Spergel J; King E; Kramer RE; Collins MH; Stucke E; Mangeot C; Jackson WD; O'Gorman M; Abonia JP; Pentiuk S; Putnam PE; Rothenberg ME
Gastroenterology; 2014 Aug; 147(2):324-33.e5. PubMed ID: 24768678
[TBL] [Abstract][Full Text] [Related]
18. Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results: Analyses From a 12-Week, Phase 2, Randomized, Placebo-controlled Trial.
Collins MH; Dellon ES; Katzka DA; Hirano I; Williams J; Lan L
Am J Surg Pathol; 2019 Nov; 43(11):1501-1509. PubMed ID: 31498177
[TBL] [Abstract][Full Text] [Related]
19. Recent insights on the use of topical steroids in eosinophilic esophagitis.
Reddy A; Ashat D; Murali AR
Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
[TBL] [Abstract][Full Text] [Related]
20. Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis.
Runge TM; Eluri S; Woosley JT; Shaheen NJ; Dellon ES
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 29206905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
